fashion -WSS

fashion

author：leisure time 2025-10-02 22:57:15 - browse：485

Mathai Mammen crosses his arms and looks into the camera — coverage from STAT — FogPharma CEO Mathai Mammen Boston Globe Photo Import

Oncology startup FogPharma just closed a $145 million Series E round, the company confirmed, reaching a late stage of financing that few other biotechs have hit in recent years.

FogPharma, which is headquartered in Cambridge, Mass., is developing cancer treatments using corkscrew-shaped peptides called helicons that could possibly better breach cells.

As CEO Mathai Mammen sees it, very few exemplary medicines shuttle off of drug companies’ pipelines, wade through clinical trials, and end up in the hands of physicians and patients in a given year. Far more often, pharma and biotech companies are pushing out drugs that are incrementally better than what came before, extending cancer patients’ survival by a few more months, halting their tumor growth for a little while longer. But FogPharma could deliver something truly unique, Mammen said.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medical records are filled with copy
Next article： Democrats are overperforming in 2023's special elections. Is it a clue for Biden vs. Trump?

WSS

Gene therapy’s promise and the high cost of hope

'Brian's Song' at 50 still offers lessons about cancer for today

Key Senate panel to consider PBM, drug pricing reform package

Prime Medicine says its gene editing passes test in monkeys

It was time to plan for my old age. If only I could stop crying

Flash flood warnings continue for parts of Missouri, Illinois

explore

fashion

focus

Walensky prepares to leave CDC — and Congress — behind

Readout Newsletter: Medeor's stem cell study, Moderna's stock dip

Medicare proposal to cover medical devices draws a mixed reaction

Flash flood warnings continue for parts of Missouri, Illinois

Medicare details structure of new drug price negotiation program

What is microchimerism and how does it affect maternal health?

Heart attack and stroke risk calculators need revising

How CRISPR works, explained in two minutes

Medical leaders decry Supreme Court decision on affirmative action

Medicare must police algorithms in Medicare Advantage, Dems say

hotspot

Flash flood warnings continue for parts of Missouri, Illinois

All of Us, NIH's precision medicine initiative, gets a big boost

Inari Medical to buy amputation prevention company LimFlow

Tuberculosis patients need more than just free medication

Many breast cancer patients receive more radiation than needed

Google's generative AI to analyze medical images — and talk to docs

hotspot

leisure time

entertainment

entertainment